Startups
Axent Biosciences
Axent Biosciences is a preclinical biotechnology company developing stem-cell therapies using engineered biomaterials. Its AXgel platform uses fully synthetic, biocompatible materials to manufacture stem cells at scale and provide protective environments for cell implantation. Its lead indication is Parkinson’s disease. The company was founded in 2019 from research in David Schaffer’s laboratory at UC Berkeley.
Founded 2019
Team
Aria KumarResearch Associate |
Corey GoodmanScientific Advisory Board Member |
Craig HalberstadtScientific Advisory Board Member |
Dana WilkinsQWEST Intern |
 David SchafferCo-founder and Chief Scientific Advisor |
Dereck RuizSenior Research Associate |
Hunter JohnsonCo-founder and Chief Executive Officer |
Jake NewsomSenior Process Engineer |
Jane LebkowskiScientific Advisory Board Member |
Kaivalya DeoSenior Scientist |
Rocío SampayoCo-founder and Chief Technology Officer |
Sungmin KimResearch Associate |
Vishaka ShahSenior Research Associate |